Respiratory news

Fluticasone/formoterol asthma combination available in new device

Fluticasone/formoterol asthma combination available in new device

Flutiform K-haler (fluticasone/formoterol) is a new...

Inhalers, a Guide to Breath-Actuated Devices

Inhalers, a Guide to Breath-Actuated Devices

Key features of dry powder and aerosol inhalers.

MIMS Respiratory and Allergy Learning workshops 2018 - chair announced

MIMS Respiratory and Allergy Learning workshops 2018 - chair announced

Book your free place for a respiratory and allergy...

New corticosteroid MDI option for asthma patients

New corticosteroid MDI option for asthma patients

Kelhale is a new metered-dose beclometasone inhaler...

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

New salmeterol/fluticasone inhaler for adult and childhood asthma

New salmeterol/fluticasone inhaler for adult and childhood asthma

The new pressurised metered-dose inhaler (MDI) Combisal...

Pressurised metered dose inhalers: MHRA warns of cap inhalation risk

Pressurised metered dose inhalers: MHRA warns of cap inhalation risk

Reports of inhaler mouthpiece covers being accidentally...

One week of steroids 'as effective as two weeks' for severe COPD

One week of steroids 'as effective as two weeks' for severe COPD

A shorter course of steroids lasting 3 to 7 days appears...

Long-acting anticholinergic licensed for childhood asthma

Long-acting anticholinergic licensed for childhood asthma

Spiriva Respimat (tiotropium) is now licensed for use...

MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced

A free full-day MIMS workshop in Glasgow has just been...

Capsule inhalation warning for tiotropium inhaler

Capsule inhalation warning for tiotropium inhaler

Train patients prescribed Braltus (tiotropium) in the...

MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced

A free full-day MIMS workshop in Liverpool has just...

Three-quarters of COPD cases linked to childhood risk factors

Three-quarters of COPD cases linked to childhood risk factors

Chronic obstructive pulmonary disease (COPD) frequently...

SMART therapy linked to better asthma outcomes

SMART therapy linked to better asthma outcomes

Single maintenance and reliever therapy (SMART) is...

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Children with mild to moderate asthma do not benefit...

MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced

A free full-day MIMS workshop in Birmingham has just...

New biologic for severe eosinophilic asthma

New biologic for severe eosinophilic asthma

Benralizumab (Fasenra) is the latest biologic to be...

Quadrupling steroid dose reduces risk of asthma exacerbations

Quadrupling steroid dose reduces risk of asthma exacerbations

Temporarily increasing the inhaled glucocorticoid dose...

New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'

New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'

A free full-day MIMS workshop has just been launched...

New once-daily triple combination inhaler for COPD

New once-daily triple combination inhaler for COPD

Trelegy Ellipta is the second 3-in-1 treatment for...

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more